Related Experiment Video
Updated: Mar 21, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Skin manifestations associated with kidney cancer
1Levine Cancer Institute at Carolinas Medical Center, Charlotte, NC.
Abstract:
Kidney cancer is a heterogenous disease encompassing several distinct clinicopathologic entities with different underlying molecular aberrations and clinical outcomes. Renal cell carcinoma (RCC) has been shown to evoke immunologic responses that can impact the natural history of disease and clinical presentation. It is important to recognize atypical presentations of disease, including cutaneous manifestations. The incidence of skin metastases from RCC is low, yet needs to be appreciated in the appropriate setting; clinical presentation for these lesions is reviewed briefly. There are several hereditary syndromes that present with well characterized cutaneous lesions and are associated with an increased risk for RCC, including Von Hippel-Lindau and Birt-Hogg-Dubé syndromes. Given that these skin lesions may be the first presenting sign for RCC, timely recognition is of essence and both are discussed in some detail. Several therapeutic options based on immunomodulation are approved for the treatment of advanced RCC. Dermatologic toxicities observed with these agents are also briefly discussed.
Insights
Recognizing skin manifestations is crucial for early kidney cancer detection, especially in hereditary syndromes like Von Hippel-Lindau and Birt-Hogg-Dubé. Prompt identification of these cutaneous signs aids in managing renal cell carcinoma (RCC).
Area of Science:
- Oncology
- Dermatology
- Genetics
Background:
- Kidney cancer, specifically renal cell carcinoma (RCC), is a complex disease with varied molecular and clinical profiles.
- Immunologic responses can influence the course and presentation of RCC.
- Atypical disease presentations, including skin manifestations, require careful recognition.
Purpose of the Study:
- To review the clinical presentation of skin metastases from RCC.
- To discuss hereditary syndromes associated with increased RCC risk and their characteristic skin lesions.
- To briefly cover dermatologic toxicities of immunomodulatory treatments for advanced RCC.
Main Methods:
- Literature review focusing on cutaneous manifestations of RCC.
- Discussion of hereditary syndromes (Von Hippel-Lindau, Birt-Hogg-Dubé) linked to RCC.
- Brief overview of immunomodulatory therapies and their dermatologic side effects.
Main Results:
- Skin metastases from RCC are rare but clinically significant.
- Hereditary syndromes like Von Hippel-Lindau and Birt-Hogg-Dubé present with distinct skin lesions and predispose to RCC.
- Cutaneous lesions can be the initial indicator of underlying RCC, necessitating timely recognition.
Conclusions:
- Timely recognition of cutaneous manifestations is essential for early diagnosis and management of renal cell carcinoma.
- Understanding the link between specific hereditary syndromes and RCC is critical for risk assessment.
- Awareness of dermatologic toxicities is important for patients undergoing immunotherapy for advanced RCC.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Nephrotic Syndrome III : Nursing Management
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nursing Assessment of the Genitourinary System II: Inspection and Palpation

